https://www.theatlantic.com/health/archive/2022/05/long-covid-treatment-pfizer-paxlovid/629810/ Meh or worse.
Interesting effect on long-covid for some. Paxlovid is to be used (per Dr. Daniel Griffin on TWIV, latest episode May 7, 2022) at least here in the USA, for people over age 65 if they have a positive test. Or anyone who has significant co-morbidities (diabetes, heart or lung disease, obesity). It is available here. Highly effective (80 some-percent) at preventing serious illness or hospitalization.
At least they are acknowledging that prescribing Paxlovid (or any antiviral) for long covid will require proper clinical trials before they can definitively say this is a treatment for long covid. But I suspect many GP’s/Family Physicians (who have this available to them) will trial this so they can at least rule out, to a degree, persistent infection, once they have properly assessed the patient, as there are several major drug interactions https://www.akohiringa.co.nz/education/treating-covid-19-with-paxlovid-in-primary-care Paxlovid is only available in NZ for people within 5 days of the start of an acute covid infection who meet certain health vulnerabilities https://pharmac.govt.nz/news-and-resources/covid19/covid-oral-antivirals
